[Federal Register Volume 71, Number 48 (Monday, March 13, 2006)]
[Proposed Rules]
[Pages 12653-12654]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-3522]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 866

[Docket No. 2005N-0471]


Immunology and Microbiology Devices; Reclassification of Herpes 
Simplex Virus (Types 1 and/or 2) Serological Assays; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Proposed rule; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration is correcting a proposed rule 
that appeared in the Federal Register of January 9, 2006 (71 FR 1399). 
That document proposed the reclassification of herpes simplex virus 
(types 1 and/or 2) serological assays from class III (premarket 
approval) to class II (special controls). That document inadvertently 
included a list of references related to a draft guidance that also was 
announced in the Federal Register of January 9, 2006 (71 FR 1432). The 
draft guidance contains the correct list of references. This document 
corrects the error.

FOR FURTHER INFORMATION CONTACT: Sally Hojvat, Center for Devices and 
Radiological Health (HFZ-440), Food and Drug Administration, 2098 
Gaither Rd., Rockville, MD 20850, 240-276-0496, ext. 114.

SUPPLEMENTARY INFORMATION: In FR Doc. 06-173, appearing on page 1399, 
in the Federal Register of Monday, January 9, 2006, the following 
correction is made:
    1. On pages 1402-1403, section XII. References is removed.


[[Page 12654]]


    Dated: March 3, 2006.
Linda S. Kahan,
Deputy Director, Center for Devices and Radiological Health.
[FR Doc. E6-3522 Filed 3-10-06; 8:45 am]
BILLING CODE 4160-01-S